IT202200007238A1 - Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche - Google Patents
Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche Download PDFInfo
- Publication number
- IT202200007238A1 IT202200007238A1 IT102022000007238A IT202200007238A IT202200007238A1 IT 202200007238 A1 IT202200007238 A1 IT 202200007238A1 IT 102022000007238 A IT102022000007238 A IT 102022000007238A IT 202200007238 A IT202200007238 A IT 202200007238A IT 202200007238 A1 IT202200007238 A1 IT 202200007238A1
- Authority
- IT
- Italy
- Prior art keywords
- acetylcysteine
- vitamin
- composition including
- nutraceutical compositions
- related pharmaceutical
- Prior art date
Links
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title 2
- 239000000203 mixture Substances 0.000 title 2
- 108010024636 Glutathione Proteins 0.000 title 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 title 1
- 229960004308 acetylcysteine Drugs 0.000 title 1
- 229960003180 glutathione Drugs 0.000 title 1
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000007238A IT202200007238A1 (it) | 2022-04-12 | 2022-04-12 | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche |
PCT/IB2023/053745 WO2023199244A1 (en) | 2022-04-12 | 2023-04-12 | Composition comprising n-acetylcysteine, vitamin d and preferably glutathione, uses thereof, and pharmaceutical and nutraceutical compositions thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000007238A IT202200007238A1 (it) | 2022-04-12 | 2022-04-12 | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202200007238A1 true IT202200007238A1 (it) | 2023-10-12 |
Family
ID=82694019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102022000007238A IT202200007238A1 (it) | 2022-04-12 | 2022-04-12 | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202200007238A1 (it) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06279397A (ja) * | 1993-03-31 | 1994-10-04 | Eisai Co Ltd | アミノ酸系末梢神経障害改善剤 |
WO1998029101A1 (en) * | 1996-12-31 | 1998-07-09 | Antioxidant Pharmaceuticals Corporation | Pharmaceutical preparations of glutathione and methods of administration thereof |
WO2005067972A1 (en) * | 2003-12-31 | 2005-07-28 | Integrative Health Consulting, Inc. | Nutrient compositions and methods for enhanced effectiveness of the immune system |
US20070116779A1 (en) * | 2005-11-23 | 2007-05-24 | Elizabeth Mazzio | Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease |
WO2010082837A1 (en) * | 2009-01-16 | 2010-07-22 | Jan Anne Lyftogt | Medicament for the treatment of pain and inflammation |
US10105419B2 (en) * | 2015-02-13 | 2018-10-23 | Eastern Vision Limited | Dietary supplements and formulations |
WO2022043407A1 (fr) * | 2020-08-25 | 2022-03-03 | Laouarem Yousra | Compositions destinées au traitement des troubles neurologiques |
-
2022
- 2022-04-12 IT IT102022000007238A patent/IT202200007238A1/it unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06279397A (ja) * | 1993-03-31 | 1994-10-04 | Eisai Co Ltd | アミノ酸系末梢神経障害改善剤 |
WO1998029101A1 (en) * | 1996-12-31 | 1998-07-09 | Antioxidant Pharmaceuticals Corporation | Pharmaceutical preparations of glutathione and methods of administration thereof |
WO2005067972A1 (en) * | 2003-12-31 | 2005-07-28 | Integrative Health Consulting, Inc. | Nutrient compositions and methods for enhanced effectiveness of the immune system |
US20070116779A1 (en) * | 2005-11-23 | 2007-05-24 | Elizabeth Mazzio | Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease |
WO2010082837A1 (en) * | 2009-01-16 | 2010-07-22 | Jan Anne Lyftogt | Medicament for the treatment of pain and inflammation |
US10105419B2 (en) * | 2015-02-13 | 2018-10-23 | Eastern Vision Limited | Dietary supplements and formulations |
WO2022043407A1 (fr) * | 2020-08-25 | 2022-03-03 | Laouarem Yousra | Compositions destinées au traitement des troubles neurologiques |
Non-Patent Citations (4)
Title |
---|
ABDUL BASIT ET AL: "Vitamin D for the treatment of painful diabetic neuropathy", BMJ OPEN DIABETES RESEARCH & CARE, vol. 4, no. 1, 1 February 2016 (2016-02-01), pages e000148, XP055645761, DOI: 10.1136/bmjdrc-2015-000148 * |
LEMON J A ET AL: "A dietary supplement abolishe age-related cognitive defcline in transgenic mice expressing elevated free radical processes", EXPERIMENTAL BIOLOGY AND MEDICINE, SAGE PUBLICATIONS LTD, GB, vol. 228, 1 January 2003 (2003-01-01), pages 800 - 810, XP002436865, ISSN: 1535-3702 * |
SAGARA M ET AL: "INHIBITION OF DEVELOPMENT OF PERIPHERAL NEUROPATHY IN STREPTOZOTOCIN-INDUCED DIABETIC RATS WITH N-ACETYLCYSTEINE", DIABETOLOGIA, SPRINGER BERLIN HEIDELBERG, BERLIN/HEIDELBERG, vol. 39, no. 3, 1 January 1996 (1996-01-01), pages 263 - 269, XP000870081, ISSN: 0012-186X, DOI: 10.1007/BF00418340 * |
UENO YUKI ET AL: "Biochemical and Molecular Actions of Nutrients Research Communication Dietary Glutathione Protects Rats from Diabetic Nephropathy and Neuropathy", 1 May 2002 (2002-05-01), XP093000918, Retrieved from the Internet <URL:https://academic.oup.com/jn/article/132/5/897/4687266?login=true> [retrieved on 20221122] * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017001847A1 (es) | Una formulación sólida de dosificación farmacéutica | |
NO20081878L (no) | Diacylindazolderivater som lipase- og fosfolipaseinhibitorer | |
ES2556585T3 (es) | Composiciones que comprenden sulfato de salbutamol | |
BRPI0608402B8 (pt) | compostos de flavonóide e composições compreendendo os mesmos | |
AR065246A1 (es) | Composiciones para mejorar la absorcion gastrointestinal de nutrientes y de farmacos | |
UY30215A1 (es) | Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones | |
BR112012006692A2 (pt) | composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas | |
BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
AR051397A1 (es) | Composicion farmaceutica | |
AR060387A1 (es) | Suplementos alimenticios y sus usos | |
CR10505A (es) | Aminopirazolopiridinas sustituidas y sus sales, sus preparaciones y composiciones farmaceuticas que las comprenden | |
BRPI0617294B8 (pt) | composição farmacêutica em gel hidroalcóolico e uso de testosterona | |
ATE511514T1 (de) | Phosphadiazin-hcv-polymerase-hemmer vom typ iv | |
WO2007036802A3 (en) | Sublingual dosage form comrising vitamin d analogue, in particular calcitriol | |
BR112016010875A8 (pt) | Composição útil para a promoção da fertilidade feminina | |
GT200800107A (es) | Formulaciones orales que comprenden tigeciclina | |
BRPI0814189A2 (pt) | Ácido ribonucleico de filamento duplo, composição farmacêutica e seus usos, método para inibir a expressão de fosfatidilinositol 4-cinase, vetor e uso de um composto que seletivamente inibe a atividade da fosfatidilinositol 4-cinase. | |
NO20054945L (no) | Orale formulering av cladribin | |
ECSP10010167A (es) | Composiciones oftálmicas novedosas | |
DK3519416T3 (da) | Chroman, isochroman og dihydroisobenzofuranderivater som mglur2-negative allosteriske modulatorer, sammensætninger og anvendelse deraf | |
NO20092763L (no) | Isosorbid mononitrat derivater for behandling av tarmlidelser | |
IT202200007229A1 (it) | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche | |
IT202200007238A1 (it) | Composizione comprendente n-acetilcisteina, vitamina d e preferibilmente glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche | |
IT202200007226A1 (it) | Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche | |
IT202200007232A1 (it) | Composizione comprendente acido lipoico, vitamina d e glutatione, suoi usi, e relative composizioni farmaceutiche e nutraceutiche |